Literature DB >> 16877934

High-flow orbital arteriovenous malformation in a child: current management and options.

Ryan Trombly1, David I Sandberg, S Anthony Wolfe, John Ragheb.   

Abstract

Vascular malformations of the orbit cause significant morbidity such as chronic pain, diplopia, amblyopia, and cosmetic disfigurement. They are rare lesions which require multidisciplinary care, and in the modern era results of treatment have been greatly improved with the assistance of endovascular therapy. Other treatment options include laser therapy, percutaneous embolization, open surgery, or a combination of these modalities. Nevertheless some patients suffer poor results despite modern medical advances. A case of an orbital arteriovenous malformation (AVM) initially treated independently by a dermatologist, a plastic surgeon, and a neuroendovascular interventionalist is presented. When treating patients with these rare but disabling lesions it is of the highest importance to coordinate efforts between all pertinent specialists in order to promote the best possible result.

Entities:  

Mesh:

Year:  2006        PMID: 16877934     DOI: 10.1097/00001665-200607000-00033

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  [Exophthalmus with enlarged epibulbar vessels].

Authors:  K Jahny; S Kösling; S Brandt; R Chapot; R Pförtner; H Thieme; C Meltendorf
Journal:  Ophthalmologe       Date:  2014-10       Impact factor: 1.059

2.  Vascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation.

Authors:  Catherine Y Liu; Marc A Yonkers; Tiffany S Liu; Don S Minckler; Jeremiah P Tao
Journal:  Ocul Oncol Pathol       Date:  2016-02-09

3.  Combined endovascular and surgical approach for the treatment of palpebral arteriovenous malformations: experience of a single center.

Authors:  F Clarençon; R Blanc; C-J Lin; C Mounayer; O Galatoire; S Morax; J Moret; M Piotin
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.